BR0209145A - Vacina contra varìola - Google Patents
Vacina contra varìolaInfo
- Publication number
- BR0209145A BR0209145A BR0209145-3A BR0209145A BR0209145A BR 0209145 A BR0209145 A BR 0209145A BR 0209145 A BR0209145 A BR 0209145A BR 0209145 A BR0209145 A BR 0209145A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- smallpox vaccine
- smallpox
- processes
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"VACINA CONTRA VARìOLA". A invenção refere-se a vacina de vírus da varíola atenuada que pode ser usada nos processos para impedir ou tratar varíola em pacientes, bem como processos para obtenção de tais vacinas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/840,751 US6723325B1 (en) | 2001-04-23 | 2001-04-23 | Smallpox vaccine |
PCT/US2002/012616 WO2002085411A1 (en) | 2001-04-23 | 2002-04-23 | Smallpox vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0209145A true BR0209145A (pt) | 2005-04-19 |
Family
ID=25283120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0209145-3A BR0209145A (pt) | 2001-04-23 | 2002-04-23 | Vacina contra varìola |
Country Status (20)
Country | Link |
---|---|
US (2) | US6723325B1 (pt) |
EP (1) | EP1381389B1 (pt) |
JP (1) | JP4397591B2 (pt) |
KR (1) | KR20040063083A (pt) |
CN (1) | CN1527722A (pt) |
AU (1) | AU2002258910B2 (pt) |
BR (1) | BR0209145A (pt) |
CA (1) | CA2444747C (pt) |
CZ (1) | CZ305819B6 (pt) |
EA (1) | EA007656B1 (pt) |
ES (1) | ES2546612T3 (pt) |
HK (1) | HK1062804A1 (pt) |
HU (1) | HU228401B1 (pt) |
IL (2) | IL158549A0 (pt) |
MA (1) | MA26270A1 (pt) |
MX (1) | MXPA03009711A (pt) |
NZ (1) | NZ529265A (pt) |
PL (1) | PL212117B1 (pt) |
WO (1) | WO2002085411A1 (pt) |
ZA (1) | ZA200309084B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723325B1 (en) * | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
US7645456B2 (en) * | 2001-04-23 | 2010-01-12 | Sanofi Pasteur Biologics Co. | Vaccinia virus strains |
WO2006113927A2 (en) * | 2005-04-20 | 2006-10-26 | University Of Washington | Immunogenic vaccinia peptides and methods of using same |
TWI417113B (zh) | 2006-11-07 | 2013-12-01 | Acambis Inc | 以凍乾法穩定疫苗 |
KR100859345B1 (ko) * | 2006-12-12 | 2008-09-19 | 씨제이제일제당 (주) | 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신 |
EA201301173A1 (ru) | 2011-04-15 | 2015-08-31 | Дженелюкс Корпорейшн | Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования |
RU2496149C1 (ru) * | 2012-06-19 | 2013-10-20 | Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") | Способ оценки противооспенной активности лечебно-профилактических препаратов |
US11345896B2 (en) | 2016-11-02 | 2022-05-31 | David Evans | Synthetic chimeric poxviruses |
US11505782B2 (en) | 2018-06-04 | 2022-11-22 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
EP3876951A1 (en) | 2018-11-06 | 2021-09-15 | Calidi Biotherapeutics, Inc. | Enhanced systems for cell-mediated oncolytic viral therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315914A (en) * | 1980-04-04 | 1982-02-16 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof |
JPS60202827A (ja) | 1984-03-28 | 1985-10-14 | Chibaken | 弱毒痘そうワクチン株 |
US5614193A (en) * | 1991-11-14 | 1997-03-25 | The United States Of America As Represented By The Secretary Of The Army | Hantavirus vaccine |
US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
US6723325B1 (en) * | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
-
2001
- 2001-04-23 US US09/840,751 patent/US6723325B1/en not_active Expired - Lifetime
-
2002
- 2002-04-23 WO PCT/US2002/012616 patent/WO2002085411A1/en active Application Filing
- 2002-04-23 EP EP02728888.5A patent/EP1381389B1/en not_active Expired - Lifetime
- 2002-04-23 HU HU0303878A patent/HU228401B1/hu unknown
- 2002-04-23 EA EA200301151A patent/EA007656B1/ru not_active IP Right Cessation
- 2002-04-23 KR KR10-2003-7013866A patent/KR20040063083A/ko active Search and Examination
- 2002-04-23 CA CA2444747A patent/CA2444747C/en not_active Expired - Lifetime
- 2002-04-23 CZ CZ2003-3184A patent/CZ305819B6/cs not_active IP Right Cessation
- 2002-04-23 CN CNA028126335A patent/CN1527722A/zh active Pending
- 2002-04-23 AU AU2002258910A patent/AU2002258910B2/en not_active Ceased
- 2002-04-23 PL PL373958A patent/PL212117B1/pl unknown
- 2002-04-23 NZ NZ529265A patent/NZ529265A/en not_active IP Right Cessation
- 2002-04-23 ES ES02728888.5T patent/ES2546612T3/es not_active Expired - Lifetime
- 2002-04-23 BR BR0209145-3A patent/BR0209145A/pt active Search and Examination
- 2002-04-23 JP JP2002582984A patent/JP4397591B2/ja not_active Expired - Fee Related
- 2002-04-23 MX MXPA03009711A patent/MXPA03009711A/es active IP Right Grant
- 2002-04-23 IL IL15854902A patent/IL158549A0/xx unknown
-
2003
- 2003-05-27 US US10/445,671 patent/US7115270B2/en not_active Expired - Lifetime
- 2003-10-22 IL IL158549A patent/IL158549A/en unknown
- 2003-11-17 MA MA27401A patent/MA26270A1/fr unknown
- 2003-11-21 ZA ZA2003/09084A patent/ZA200309084B/en unknown
-
2004
- 2004-07-10 HK HK04105036.1A patent/HK1062804A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2444747C (en) | 2018-04-17 |
EP1381389A4 (en) | 2004-07-28 |
WO2002085411A1 (en) | 2002-10-31 |
IL158549A0 (en) | 2004-05-12 |
HK1062804A1 (en) | 2004-11-26 |
MXPA03009711A (es) | 2005-03-07 |
AU2002258910B2 (en) | 2007-10-25 |
CN1527722A (zh) | 2004-09-08 |
MA26270A1 (fr) | 2004-09-01 |
EA007656B1 (ru) | 2006-12-29 |
HUP0303878A3 (en) | 2010-01-28 |
KR20040063083A (ko) | 2004-07-12 |
CZ20033184A3 (cs) | 2004-04-14 |
CZ305819B6 (cs) | 2016-03-30 |
US6723325B1 (en) | 2004-04-20 |
JP4397591B2 (ja) | 2010-01-13 |
PL373958A1 (en) | 2005-09-19 |
HUP0303878A2 (hu) | 2004-03-01 |
CA2444747A1 (en) | 2002-10-31 |
US20060153873A1 (en) | 2006-07-13 |
EA200301151A1 (ru) | 2004-10-28 |
ZA200309084B (en) | 2005-01-26 |
US7115270B2 (en) | 2006-10-03 |
NZ529265A (en) | 2006-04-28 |
JP2005503126A (ja) | 2005-02-03 |
ES2546612T3 (es) | 2015-09-25 |
HU228401B1 (en) | 2013-03-28 |
PL212117B1 (pl) | 2012-08-31 |
EP1381389B1 (en) | 2015-08-26 |
EP1381389A1 (en) | 2004-01-21 |
IL158549A (en) | 2009-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
PL375621A1 (en) | Pharmaceutical compositions comprising flavonoids and menthol | |
EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
NO20061911L (no) | Immunogene sammensetninger | |
MY144616A (en) | Substituted dihydroquinazolines | |
ATE452900T1 (de) | Impfstoff gegen das west-nile-virus | |
DE60023300D1 (de) | Verwendung von cpg als adjuvans für hivimpstoff | |
BR0209145A (pt) | Vacina contra varìola | |
BR0315437A (pt) | Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos | |
NO331082B1 (no) | Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft | |
BR0310046A (pt) | Atenuação de metapneumovìrus | |
AU6365301A (en) | Vaccine | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol | |
PT1255538E (pt) | Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros | |
BR9808226A (pt) | Coronavìrus respiratório bovino como uma vacina | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
EE200300213A (et) | SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks | |
DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
TR200002847T2 (tr) | Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol. | |
DK1227826T3 (da) | Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: ACAMBIS, INC. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI PASTEUR BIOLOGICS CO. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI PASTEUR BIOLOGICS, LLC (US) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |